Notogen is an early-stage biotechnology company developing a novel biologic regenerative therapy for the large market and unmet need of degenerative disc disease (DDD, i.e. chronic back and neck pain due to degenerating spinal discs). Notogen is the only non-cellular, but regenerative biologic therapy in development, has compelling pre-clinical data and is currently seeking investors or partners to support a Phase 1/2a clinical trial planned for 2022.

Notogen Inc. Logo



Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


30 in total